126 related articles for article (PubMed ID: 9346673)
1. Increased expression of proliferating cell nuclear antigen in liver allograft rejection.
Ray MB; Schroeder T; Michaels SE; Hanto DW
Liver Transpl Surg; 1996 Sep; 2(5):337-42. PubMed ID: 9346673
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen expression in normal, regenerative, and neoplastic liver: a fine-needle aspiration cytology and biopsy study.
Ojanguren I; Ariza A; Llatjós M; Castellà E; Mate JL; Navas-Palacios JJ
Hum Pathol; 1993 Aug; 24(8):905-8. PubMed ID: 7690737
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic proliferation of 'naive' and 'memory' T cells during liver allograft rejection: primary immune response within the allograft.
Dollinger MM; Howie SE; Plevris JN; Graham AM; Hayes PC; Harrison DJ
FASEB J; 1998 Aug; 12(11):939-47. PubMed ID: 9707166
[TBL] [Abstract][Full Text] [Related]
4. Deletion variant of hepatocyte growth factor prolongs allograft survival after liver transplantation in rats.
Ikegami T; Nishizaki T; Uchiyama H; Kakizoe S; Yanaga K; Sugimachi K
Surgery; 1999 Jun; 125(6):602-7. PubMed ID: 10372025
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the rate of progression of chronic renal transplant rejection using the proliferating cell nuclear antigen ].
Simić-Ogrizović S; Starcević-Bozović A; Blagojević R; Radivojević D; Djkanović L
Srp Arh Celok Lek; 2002; 130(5-6):159-64. PubMed ID: 12395435
[TBL] [Abstract][Full Text] [Related]
6. Analysis of proliferating cell nuclear antigen expression aids histological diagnosis and is predictive of progression of human cardiac allograft rejection.
Salom RN; Maguire JA; Esmore D; Hancock WW
Am J Pathol; 1994 Oct; 145(4):876-82. PubMed ID: 7943178
[TBL] [Abstract][Full Text] [Related]
7. Intragraft events preceding chronic renal allograft rejection in a modified tolerance protocol.
Shimizu A; Yamada K; Sachs DH; Colvin RB
Kidney Int; 2000 Dec; 58(6):2546-58. PubMed ID: 11115090
[TBL] [Abstract][Full Text] [Related]
8. Correlation between acute rejection severity and CD8-positive T cells in living related liver transplantation.
Kubota N; Sugitani M; Takano S; Sheikh A; Takayama T; Haga H; Tanaka K; Yamabe H
Transpl Immunol; 2006 Jun; 16(1):60-4. PubMed ID: 16701178
[TBL] [Abstract][Full Text] [Related]
9. FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations.
Hytiroglou P; Lee R; Sharma K; Theise ND; Schwartz M; Miller C; Thung SN
Transplantation; 1993 Dec; 56(6):1389-94. PubMed ID: 7506452
[TBL] [Abstract][Full Text] [Related]
10. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection.
Krukemeyer MG; Moeller J; Morawietz L; Rudolph B; Neumann U; Theruvath T; Neuhaus P; Krenn V
Transplantation; 2004 Jul; 78(1):65-70. PubMed ID: 15257040
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) as a diagnostic marker of acute cellular rejection in routinely processed biopsies of renal allografts.
Thom M; Palmer A; Cattell V; Cook T
Nephrol Dial Transplant; 1994; 9(2):153-5. PubMed ID: 7910676
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the Fas system in liver allograft rejection.
Rivero M; Crespo J; Mayorga M; Fábrega E; Casafont F; Pons-Romero F
Am J Gastroenterol; 2002 Jun; 97(6):1501-6. PubMed ID: 12094873
[TBL] [Abstract][Full Text] [Related]
13. ICAM-1 induction on hepatocytes as a marker for immune activation of acute liver allograft rejection.
Lautenschlager IT; Höckerstedt KA
Transplantation; 1993 Dec; 56(6):1495-9. PubMed ID: 7904090
[TBL] [Abstract][Full Text] [Related]
14. Induction of ICAM-1 on hepatocytes precedes the lymphoid activation of acute liver allograft rejection and cytomegalovirus infection.
Lautenschlager I; Höckerstedt K
Transplant Proc; 1993 Feb; 25(1 Pt 2):1429-30. PubMed ID: 8095108
[No Abstract] [Full Text] [Related]
15. Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling.
Rudi J; Waldherr R; Raedsch R; Kommerell B
J Hepatol; 1995 Jan; 22(1):43-9. PubMed ID: 7751586
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class II antigen expression in rejecting cardiac allografts: detection using in vivo imaging with radiolabeled monoclonal antibody.
McGhie AI; Radovancevic B; Capek P; Moore WH; Kasi L; Lamki L; Clubb FJ; Frazier OH; Willerson JT
Circulation; 1997 Sep; 96(5):1605-11. PubMed ID: 9315554
[TBL] [Abstract][Full Text] [Related]
17. Serum vitamin A deficiency and increased intrahepatic expression of cytokeratin antigen in alcoholic liver disease.
Ray MB; Mendenhall CL; French SW; Gartside PS
Hepatology; 1988; 8(5):1019-26. PubMed ID: 2458308
[TBL] [Abstract][Full Text] [Related]
18. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
[TBL] [Abstract][Full Text] [Related]
19. Intercellular adhesion molecule 1 (ICAM-1) induction on hepatocytes is an early marker of acute liver allograft rejection.
Lautenschlager I; Höckerstedt K; Häyry P
Transpl Int; 1992; 5 Suppl 1():S283-5. PubMed ID: 14621802
[TBL] [Abstract][Full Text] [Related]
20. Role of liver allograft biopsy in patient management.
Williams JW; Foster PF; Sankary HN
Semin Liver Dis; 1992 Feb; 12(1):60-72. PubMed ID: 1570552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
